.Merck beats revenues requirements, rears purchases expectation on tough need for leading medications like Keytruda CNBCMerck & Co. (MRK US) Beats Income Estimates as Keytruda Sales Surge BloombergMerck Sell: Pharma Giant Posts Sturdy End Results, But Outlook Tumbles Short Investor's Service DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats income as well as purchases desires among Keytruda advantage, however gives blended full-year overview MarketWatch.